Indapamide and Chlorthalidone to Reduce Urine Supersaturation for Kidney Stone Prevention
Conditions: Kidney Stone Interventions: Drug: Indapamide 2.5 MG; Drug: Hydrochlorothiazide 50Mg; Drug: Chlorthalidone 25mg Sponsors: Insel Gruppe AG, University Hospital Bern; University of Bern Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Hospitals | Hydrochlorothiazide | Indapamide | Kidney Stones | Research | Urology & Nephrology